Ki Ryang Na

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 215 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +13

Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury

Yoon‐Kyung Chang, Hyunsu Choi, Jin Young Jeong et al. · PLoS ONE · 2016 · 176 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Prevention of Acute Kidney Injury by Erythropoietin in Patients Undergoing Coronary Artery Bypass Grafting: A Pilot Study

Young Rim Song, Taewoo Lee, Sun Jin You et al. · American Journal of Nephrology · 2009 · 152 citations

Medicine, Perioperative Medicine, Surgery +13

Pretreatment of sildenafil attenuates ischemia-reperfusion renal injury in rats

Dae Eun Choi, Jin Young Jeong, Beom Jin Lim et al. · American Journal of Physiology-Renal Physiology · 2009 · 115 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction

Ran‐hui Cha, Shin‐Wook Kang, Cheol Whee Park et al. · Clinical Journal of the American Society of Nephrology · 2016 · 90 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17